The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
The Scientist
Most Recent
The 2011 outbreak in Germany that caused some 50 deaths was caused by a strain of E. coli with a complex mechanism of gene regulation.
Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.
Recording brain activity as patients are anesthetized for surgery, researchers identify a pattern that may signal loss of consciousness.
Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.
Contributors
| November 1, 2012
Meet some of the people featured in the November 2012 issue of The Scientist.
Successive awakening of soil microbes drives a huge pulse of CO2 following the first rain after a dry summer.
Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.
First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.
After two headline successes, companies rush to develop “smart bomb” cancer drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
